6th Intl Congress on Drug Therapy in HIV Infection

Conference Reports for NATAP


6th Intl Congress on Drug Therapy in HIV Infection Glasgow, Scotland Nov 17-20, 2002

	Tenofovir Resistance in Treatment-Naive Individuals, FDA Approval Report from 6th Glasgow Conference on HIV - Written for NATAP by Grame Moyle, MD, Chelsea & Westminster Hospital, London, UK and Jules Levin - (12/13/02) 6th Intl Congress on Drug Therapy in HIV - Written by Graeme Moyle, MD, Chelsea & Westminster Hospital, London, UK - (12/5/02) TDM (Therapeutic Drug Monitoring) - (12/2/02) Report from 6th Intl Congress on Drug Therapy in HIV-Infection Reported by Mike Youle, MD, Royal Free Hospital, London, UK - (12/2/02) How Low Does Your Viral Load Have To Be: Kaletra plus d4T/3TC - (11/25/02) Patients with HIV live longer but face new challenges - (11/21/02) 48-Week Results of Study Comparing New Version of Amprenavir Once-A-Day to Nelfinavir Twice-A-Day Presented at Glasgow International HIV Meeting - (11/21/02)